1. Home
  2. TIVC vs DRMA Comparison

TIVC vs DRMA Comparison

Compare TIVC & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TIVC
  • DRMA
  • Stock Information
  • Founded
  • TIVC 2016
  • DRMA 2014
  • Country
  • TIVC United States
  • DRMA United States
  • Employees
  • TIVC N/A
  • DRMA N/A
  • Industry
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • DRMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • TIVC Health Care
  • DRMA Health Care
  • Exchange
  • TIVC Nasdaq
  • DRMA Nasdaq
  • Market Cap
  • TIVC 1.8M
  • DRMA 1.7M
  • IPO Year
  • TIVC 2021
  • DRMA 2021
  • Fundamental
  • Price
  • TIVC $0.29
  • DRMA $1.12
  • Analyst Decision
  • TIVC
  • DRMA Strong Buy
  • Analyst Count
  • TIVC 0
  • DRMA 1
  • Target Price
  • TIVC N/A
  • DRMA $6.00
  • AVG Volume (30 Days)
  • TIVC 16.2M
  • DRMA 85.2K
  • Earning Date
  • TIVC 11-14-2024
  • DRMA 11-13-2024
  • Dividend Yield
  • TIVC N/A
  • DRMA N/A
  • EPS Growth
  • TIVC N/A
  • DRMA N/A
  • EPS
  • TIVC N/A
  • DRMA N/A
  • Revenue
  • TIVC $957,000.00
  • DRMA N/A
  • Revenue This Year
  • TIVC $324.15
  • DRMA N/A
  • Revenue Next Year
  • TIVC N/A
  • DRMA N/A
  • P/E Ratio
  • TIVC N/A
  • DRMA N/A
  • Revenue Growth
  • TIVC N/A
  • DRMA N/A
  • 52 Week Low
  • TIVC $0.22
  • DRMA $1.11
  • 52 Week High
  • TIVC $3.21
  • DRMA $13.35
  • Technical
  • Relative Strength Index (RSI)
  • TIVC 47.33
  • DRMA 34.78
  • Support Level
  • TIVC $0.24
  • DRMA $1.22
  • Resistance Level
  • TIVC $0.45
  • DRMA $1.54
  • Average True Range (ATR)
  • TIVC 0.06
  • DRMA 0.12
  • MACD
  • TIVC 0.00
  • DRMA -0.01
  • Stochastic Oscillator
  • TIVC 12.12
  • DRMA 2.35

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

Share on Social Networks: